Home » Hawaii Biotech Initiates Phase I Trial for Dengue Vaccine
Hawaii Biotech Initiates Phase I Trial for Dengue Vaccine
Hawaii Biotech, Inc. President and CEO Elliot Parks, Ph.D., announced Tuesday that the company has initiated a Phase 1 clinical study with its monovalent dengue vaccine candidate.
Earth Times
Earth Times
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May